stella
beta
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer — Stella
Recruiting
Back to Pancreatic Ductal Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Baylor College of Medicine, Houston, Texas
Baylor St. Luke's Medical Center (BSLMC)., Houston, Texas
Houston Methodist Hospital, Houston, Texas
View full record on ClinicalTrials.gov